Author to Guidelines

 | Post date: 2019/06/25 | 
General Information
The Journal of Toloo-e-Behdasht in continuous publication , is a peer review Bimonthly journal and publishes original papers related to all areas of basic and biomedical sciences with a special approach to disease prevention & community health promotion.This journal welcomes all researchers working in the different fields of health. All manuscripts must be submitted online via the Toloo-e-Behdasht online manuscript submission and review system at http://www.tbj .ssu.ac.ir.
Aim & Scope
The open access Journal has been published with the objective of increasing the knowledge of its readers as well as providing a platform for the interchange of scientific experiences and debates. The journal of Toloo-e-Behdasht is a peer-review bimonthly journal that publishes original papers related to all areas of basic and biomedical sciences with a special approach to disease prevention and community health promotion. This journal welcomes all researchers working in the different fields of health. Manuscripts are accepted on the condition that they have not been previously published, submitted for publication, or are not going to be sent to other journals.
This Journal will receive the following fields:
·         Health education and promotion programs effectiveness
·         Public health practices and their impacts
·         Health promotion and disease prevention
·         Health psychology and Social determinants of health
·         Healthy nutrition in the community level and Food Safety
·         Environmental health management
·         Ergonomics and occupational health promotion
·         Epidemiology and Biostatics
·         Human ecology
Ethical Consideration
This Journal is not a member of the committee on Publication Ethics (COPE), but uses the COPE's flowcharts and guidelines. It also follows the guidelines mentioned in the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals issued by the International Committee of Medical Journal Editors (ICMJE) (http://www.icmje.org/#privacy). We're trying to be a member of COPE in the future.

Authorship Criteria and Contribution
 The journal adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). The ICMJE recommends that authorship should be based on the following 4 criteria: i) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; ii) Drafting the work or revising it critically for important intellectual content; iii) Final approval of the version to be published; and iv) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

 All persons, designated as authors, should be qualified for authorship and all those who are qualified should be listed in the manuscript. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. One or more authors should take responsibility for the integrity of the work as a whole, from inception to published article. Authorship credit should be based only on 1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; 3) final approval of the version to be published. Conditions 1, 2, and 3 must all be met. Acquisition of funding, collection of data, or general supervision of the research group do not justify authorship. All others who contributed in the work and  are not authors should be named in the Acknowledgements section.

Based on the recommendations by the ICMJE about conducting, reporting, editing, and publishing scholarly works in medical journals, all authors should have made significant conceptual, intellectual, experimental, and analytical contributions in the research. They also should have participated in writing and revising the manuscript. In addition, each author should have participated sufficiently in the work to be responsible for its content. All authors should meet the mentioned criteria in ICMJE about authorship and in the case that they do not meet the required criteria, they will be omitted from the list.
The authors should ensure that all people who provided general support including technical and composition assistance or even a department chairperson should be listed in the acknowledgment section. The copyright should contain written authorization from all authors for publication of the manuscript. Authors should agree over the order of authors listed in the manuscript before submitting it.

The authors also must certify that the manuscript represents valid data, has not been published in any form, and is not being submitted in the form of scientific presentations for publication elsewhere.

All authors must sign the  Toloo-e-Behdasht  Authorship Form (typed or printed name is not acceptable) and include the form on initial submission. 

CConflict of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. If you have no competing interests please state 'I/We have no conflict of interests. Authors must acknowledge and declare any sources of funding and potential conflicting interest, such as receiving funds or fees by, or holding stocks and shares in an organization that may profit or lose through publication of their paper.

Disclosure
At the time of submission, the corresponding author must include a disclosure statement in the body of the manuscript. All authors are required to disclose all potential conflicts of interest, including specific financial interests, relationships, and affiliations (other than those affiliations listed in the title page of the manuscript) relevant to the subject of their manuscript. This information should be provided under the heading titled ‘Conflicts of interest’, which should appear after the ‘Author contributions’ section and before the ‘References’ section. Authors without conflicts of interest, including specific financial interests, relationships, and affiliations relevant to the subject of their manuscript, should include a statement of "I/We have no conflict of interests" in the Disclosure section of the manuscript. Failure to include this information in the manuscript may delay the evaluation and review process.

 
Principles for Publication of Research Involving Human Subjects
Manuscripts must contain a statement indicating that all human studies have been reviewed by the appropriate ethics committee and have been performed in accordance with the ethical standards laid down in an appropriate version of the Declaration of Helsinki (as revised in Brazil 2013), available at http://www.wma.net/en/30publications/10policies/b3/index.html. It should also be stated clearly in the text that all persons gave their informed consents prior to their inclusion in the study. Details that might disclose the identity of the participants should be omitted. Photographs should be cropped sufficiently to prevent recognition  (or an eye bar should be used).

In general, submission of a case report should be accompanied by the written consent of the individual (or parent/guardian) before publication; this is particularly important where photographs are to be used or in cases where the unique nature of the incident reported makes it possible for the patients to be identified. While the Editorial Board recognizes that it might not always be possible or appropriate to seek such consent, the onus will be on the authors to demonstrate that this exception applies in their case.
Any experiments involving animals must be demonstrated to be ethically acceptable and must conform to the international guidelines for animal usage in research, such as those of the US NIH or the UK Home Office.
 
Clinical Trials Registry
We require, as a condition of publication consideration, registration in a public trial registry. Trials must be registered at or before the onset of patients' enrollment. This [a1] policy should be applied to all clinical trials that started their enrollment after January 1, 2006. For trials that began enrollment before this date, we require registration by April 1, 2006, before considering the trial for publication. We define a clinical trial as any research project that prospectively assigns human participants to intervention or comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Studies designed for other purposes, such as pharmacokinetics or major toxicity (e.g., phase 1 trials) are exempt.
We do not advocate one particular registry, but registration must meet the following minimum criteria: (1) accessible to the public at no charge; (2) searchable by standard, electronic (Internet-based) methods; (3) open to all prospective registrants free of charge or at minimal cost; (4) validate registered information; (5) identify trials with a unique number; and (6) include information on the investigator(s), research question or hypothesis, methodology, intervention and comparisons, eligibility criteria, primary and secondary outcomes measured, date of registration, anticipated or actual start date, anticipated or actual date of last follow-up, target number of participants, status (anticipated, ongoing or closed), and funding source(s).

Registries that currently meet these criteria include: (1) the registry sponsored by the United States National Library of Medicine; (2) the International Standard Randomized Controlled Trial Number Registry; (3) the Australian New Zealand Clinical Trials Registry (ANZCTR); (4) the Chinese Clinical Trials Register; (5) the Clinical Trials Registry - India and (6) the Iranian Clinical Trial Registration (www.IRCT.IR).

All Iranian Clinical Trials must be registered in Iranian Registry of Clinical Trials (www.IRCT.ir) to be considered for publication. The clinical trials performed abroad can be considered for publication, if they register in a registration site approved by W.H.O. such as:

http://rctregistry.tums.ac.ir
-http://www.clicicaltrials.gov
http://www.anzctr.org.au
http://isrctn.org
- http:// www.trialregister.nl/trialreg/index.asp
http://www.umin.ac.jp/ctr
Randomized control trials

Reporting of randomized controlled trials should follow the guidelines of The CONSORT Statement.
 


Scientific Misconducts

Fabrication: Fabrication is the intentional misrepresentation of research results by making up data, such as that reported in a journal article. As with other forms of scientific misconduct, its intent is to deceive. This marks fabrication as highly unethical and different from scientists self-deceiving. In some jurisdictions, fabrication may be illegal.

Falsification: Falsified evidence can be created by either side in a case (including the police/prosecution in a criminal case) or by someone sympathetic to one side. Misleading by suppressing evidence can also be considered a form of false evidence (by omission).

Plagiarism: Plagiarism of text from a previously published manuscript by the same or another author is a serious publication offence. Small amounts of text may be used, but only where the source of the material is quoted and clearly acknowledged. Fraudulent data or data stolen from other authors are also unethical and will be treated accordingly. Any alleged offence is considered initially by the Editorial Board.

 The journal employs a plagiarism detection system to check all manuscripts for plagiarism against previously published works.
 
Page Charges

There is no page charge for article submission, processing, or publication in the Journal of Toloo-e-Behdasht.

Submission structure

The Toloo-e-Behdasht Journal is a peer-review bimonthly journal and publishes original papers related to all areas of basic and biomedical sciences with a special approach to disease prevention and community health promotion. The journal welcomes all researchers working in the different fields of health. Manuscripts are accepted on condition that they have not been previously published or submitted for publication and are not going to be sent to other journals. Language and style: Contributions should be in Persian with English abstracts. Nonnative Persian speakers may be advised to seek professional help with the language. All materials should be typed in double line spacing numbered pages. Abbreviations should be standardized and used just in necessary cases, after complete explanations in the first usage. Form of manuscript: Title page of the article should include
1) the title of the article;
2) authors' names;
3) name of the institution where the work was done;
4) running title (short form of the main title presented at the top of pages); and
5) complete mailing address, telephone/ Fax numbers, and email address of the corresponding author.
This page is unnumbered.
The abstract should be structured for original articles providing introduction for the study; materials and methods, results and conclusion altogether should not exceed 250 words. Number this as page 1. The abbreviations should not preferably be mentioned in the abstract. Keywords are used for indexing purpose: each article should provide three to five keywords according to the medical subject Headings (MESH).

Introduction: Should provide a background and specifies the research objective of the study or observation. 

Materials and Methods: Must indicate clearly the steps taken to acquire the information. It should be detailed (including: controls, inclusion and exclusion criteria etc.). Repeating the details of standard techniques should be avoided. The software used for statistical analysis and description of the actual method should be mentioned.

Results: The results should be presented in chronological sequence in the text, table, and illustration. Organize the results according to their importance. The findings should be derived from your own study. Tables and illustrations, if any, have to be cited in the text using Arabic numerals. Tables should be simple and the data should not be duplicated in the text of the article. Figures should be presented only if they improve the article.
Discussion and conclusion: They should emphasize the new and important aspects of the study and the conclusion derived from them. Possible explanations for these findings should be mentioned. The limitations of the work and implications of the findings should be noted for future research.

Acknowledgments 
All contributors who do not meet the criteria for authorship should be covered in the acknowledgement section. Financial and material support should also be acknowledged. Personal acknowledgement should precede those of institutions or agencies. Moreover,   any technical help, general, financial, and material support or contributions should be mentioned and acknowledged (do not justify the authorship)

Authors' contributions
After the “Acknowledgements” section, authors must indicate their contribution(s) in the manuscript in "Authors' contributions" section.Use the relevant descriptors listed below unless the author performed a function that is clearly not covered by one of the following ideas. All manuscripts, including reviews, must indicate who is responsible for design,composition writing, and final Acknowledgments 
All contributors who do not meet the criteria for authorship should be covered in the acknowledgement section. Financial and material support should also be acknowledged. Personal acknowledgement should precede those of institutions or agencies. Moreover,   any technical help, general, financial, and material support or contributions should be mentioned and acknowledged (do not justify the authorship)

content. They also must include a statement affirming that all authors have read and approved the manuscript. The initials of all authors' first names must be included.  All authors' contribution statements must include:
  • Designed research (project concept, development of overall research plan, and study oversights)
  • Conducted research (conductance of the experiments and data collection).
  • Provided essential reagents, or provided essential materials (applies to authors who contributed by providing animals, constructs, databases, etc., necessary for the research).
  • Analyzed data or performed statistical analysis.
  • Wrote the paper (only authors who made a major contribution).
  • Had primary responsibility for final content.
  • Other (use only the mentioned categories are not applicable; describe briefly).
  • All authors have read and approved the final manuscript. For single-authored research papers and reviews, please state: The sole author is responsible for all parts of the manuscript.
For example:ss Mazloomy, A  Rahmati, and P Hashemi designed research; ss Mazloomy and B. Mohammadi conducted research; P. Khosravi analyzed data; and A. Rahmati, P. Hashemi and B. Mohammadi wrote the paper. ss Mazloomy had primary responsibility for final content. All authors read and approved the final manuscript.  
 
Ethical guidelines
Ethical considerations must be addressed in the "Material and Methods" section.
- When reporting studies on human beings, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 2000 (available at http://www.wma.net/e/policy/17-c_e.html). Evidence for approval by a local Ethics Committee (for both human as well as animal studies) must be supplied by the authors on demand. The journal will not consider any paper ethically unacceptable. A statement on ethics committee permission and ethical practices must be included in all research articles under the Materials and Methods section.
Referencing: References should be numbered consecutively as they appear in the text. Bibliographies cited in tables and figures should be numbered according to the site where the corresponding table or figure was first referenced. Periodical should be abbreviated according to the Index Medicus. Include the name of all authors, if there are four or less authors. Print names of the first three authors followed by "et al."
 Journal article: Smithline HA, Mader TJ, Ali FM, Cocchi MN. The determining pretest probability of DVT: clinical intuition vs. validated scoring systems. N Engl J Med. 2003 Apr 4;21(2):161-2.
Complete Book: Guyton AC: textbook of medical physiology. 8th ed. Philadelphia, PA, Saunders, 1996. Chapter in Book: Blaxter PS, Farnsworth TP. Social health and class inequalities. In: Carter C, Peel JR, editors. Equalities and inequalities in health. 2nd ed. London: Academic Press; 1976. p. 165-78. Letter to the Editor: Toloo-e-Behdasht welcomes letters to the Editor pointing out alternative interpretations of published results, or commenting briefly on topics of relevance to the journal's readers
This is hereby to confirm that I, ……………………………………, as the corresponding author of this article, while observing the regulations of article writing model and filling in “Form No. 1” (Checklist for Article Submission), submit my article indexed to this letter to be considered for publication in EDC journal and accept the following commitments:
  -The submitted article has no history of acceptance or publication in any other journal and has not been sent simultaneously to any other journal. It won’t be sent to any other journal to be considered for publication till I receive the final result of referee processing of this journal.
  -I announce my readiness to do any corrections if needed till the publication phase and grant the copyright of this article to that journal.
  -This article has been prepared by the cooperation of all of the following authors:
  Name Date Signature
  1. ……………………………………………….
  2. ……………………………………………….
  3. ……………………………………………….
  4. ……………………………………………….
  5. ……………………………………………….

Review process
The submitted manuscripts will be assessed from editorial points of view, at first. The manuscript should meet the basic editorial requirements; it will enter the peer-review process. The manuscript will then be sent at least to one in-office and two out-of-office referees for review. The corresponding author will then be informed about the referee’s remark to accept, reject or require modification.
Revision: Papers may be returned to authors for modification of the scientific content and/or for language corrections. Revised paper and a letter listing point-for-point response to the reviewers must be submitted to the Editor and must be accompanied by a copy of the original version. Suggestion by the Editor about resubmission does not imply that a revised version will be accepted necessarily. If a paper that is returned to the authors for modification is not resubmitted within two months it will be regarded as withdrawn and any revised version received subsequently will be treated as a new paper and the date of receipt will be altered accordingly. Authors who resubmit a paper that has previously been rejected must provide the original manuscript and a letter explaining in details how the paper has been modified. Accepted manuscripts become the property of the journal of Toloo-e-Behdasht.
Proofs: A computer printout will be sent to the corresponding author to be checked for only typographical errors and other essential small changes before publication in order to avoid any mistakes. Major alternations to the text cannot be accepted at this stage. Proofs must be returned to the Editor within 3 days of receipt.

Archiving policy
The articles published by Toloo-e-Behdasht are archived on our website and also in multiple international databases around the world that  increase visibility and long-term digital preservation.
These archives include:
Google Scholar
DOAJ (Directory of Open Access Journals)
Index Copernicus
ISC (Islamic World Science Citation Center)
magiran
All journal issues are archived in the library of School of Public Health in Shahid Sadoughi University of Medical Sciences.


Complaints Procedures
This procedure applies to complaints about the policies, procedures, or actions of the Toloo-e-Behdasht Editorial Board. We welcome complaints as they provide an opportunity and a spur for improvement. We  aim to respond quickly, courteously, and constructively. The following procedures are followed:
Definition
Our definition of a complaint is as follows:
  • The complainant expresses his or her expression of unhappiness as a complaint.
  •  We infer that the complainant is not simply disagreeing with a decision we have made or something we have published (which happens every day) but thinks that there has been a failure of process; for example, a long delay, a rude response, or a severe misjudgment.
  •  The complaint must be about something that is within the responsibility of The Toloo-e-Behdasht editorial board  - content or process.
How to Make a Complaint
  • The best way to reach us is by email. Complaints should ideally be made to the person the complainant is already in contact with over the problematic matter. If that is not appropriate, please email Toloo-e-Behdasht ssu.ac.ir
  •  Whenever possible, complaints will be processed by the relevant member of the Editorial Board. If that person cannot deal with the complaint, it will be referred to the appropriate section editor or the executive editor.
  •  Complaints that are not under the control of the Toloo-e-Behdasht Editorial Board will be sent to chairman of the Toloo-e-Behdasht .
  •  All complaints will be acknowledged within seven working days.
  • If possible, a full response will be made within four weeks. If this is not possible, an interim response will be given within four weeks. Further interim responses will be provided until the complaint is resolved.
  •  If the complainant is not happy with the resolution, s/he can ask for the complaint to be forwarded to the Ethics Committee at School of Public Health at  Shahid Sadoughi University of Medical Sciences.
  • If the complainant remains unhappy, complaints should be forwarded to the  Shahid Sadoughi University of Medical Sciences Ethics Committee, whose decision is final.
  •  If a complainant remains unhappy after what the chancellor’s final decision, the complainant may complain tot he Committee on Publication Ethics (COPE). This committee publishes publishes a code of practice for editors of scientific, technical, and medical journals http://www.publicationethics.org. It will consider complaints against editors but only once a journal's own complaints procedures have been exhausted.

Retraction Policy
 
For retraction of a published article Toloo-e-Behdasht journal uses the COPE flowchart (http://publicationethics.org/resources/guidelines)
 
Copyright Policy
 All articles published in Toloo-e-Behdasht are open access which means the articles are freely available online for anyone to download and use the providing address to the individual authors. In this journal as an open access journal, authors sign a publishing agreement where they will have copyright but grant the broad publishing and distribution rights to the publisher, including the right to publish the article on Toloo-e-Behdasht 's website and choose the end-user license under which readers can use and share the articles. Then Toloo-e-Behdasht provides the article's online access for using and sharing by readers.
Open Access (OA)
The journal of Toloo-e-Behdasht  is a non-for-profit journal. As an open access journal, this journal makes all publications immediately available to all readers worldwide, There are no publication fees and submission fees. All articles will be immediately and permanently free for all users to read and download upon publication. Permitted (re) use is defined by the Creative Commons Attribution (CC BY).
Creative Commons Attribution (CC BY): this permits the users to copy , to create extracts abstracts, abstracts and new works from the articles, to alter and revise the article, and to make commercial use of the articles.
 

View: 273 Time(s)   |   Print: 47 Time(s)   |   Email: 0 Time(s)   |   0 Comment(s)

© 2019 All Rights Reserved | Tolooebehdasht

Designed & Developed by : Yektaweb